Immunomodulatory treatments for relapsing–remitting multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that encompasses both neuroinflammatory and prominent neurodegenerative aspects. A significant proportion of MS patients will develop neurological disability over time and, until recently, licensed drugs could not satisfa...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Series: | Hamdan Medical Journal |
| Online Access: | http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2017;volume=10;issue=4;spage=213;epage=226;aulast=Leutmezer;type=0 |